Literature DB >> 26688279

Immunogenicity and protective efficacy of Clostridium difficile spore proteins.

Chandrabali Ghose1, Ioannis Eugenis2, Adrianne N Edwards3, Xingmin Sun4, Shonna M McBride3, David D Ho5.   

Abstract

Clostridium difficile is a spore-forming, anaerobic, Gram-positive organism that is the leading cause of antibiotic-associated infectious diarrhea, commonly known as C. difficile infection (CDI). C. difficile spores play an important role in the pathogenesis of CDI. Spore proteins, especially those that are surface-bound may play an essential role in the germination, colonization and persistence of C. difficile in the human gut. In our current study, we report the identification of two surface-bound spore proteins, CdeC and CdeM that may be utilized as immunization candidates against C. difficile. These spore proteins are immunogenic in mice and are able to protect mice against challenge with C. difficile UK1, a clinically-relevant 027/B1/NAP1 strain. These spore proteins are also able to afford high levels of protection against challenge with C. difficile 630Δerm in golden Syrian hamsters. This unprecedented study shows the vaccination potential of C. difficile spore exosporium proteins.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BclA1; CdeC; CdeM; Clostridium difficile; CotA; Exosporium; Spores; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26688279      PMCID: PMC4770901          DOI: 10.1016/j.anaerobe.2015.12.001

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  41 in total

1.  Functional characterization of Clostridium difficile spore coat proteins.

Authors:  Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting
Journal:  J Bacteriol       Date:  2013-01-18       Impact factor: 3.490

2.  The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome.

Authors:  Mohammed Sebaihia; Brendan W Wren; Peter Mullany; Neil F Fairweather; Nigel Minton; Richard Stabler; Nicholas R Thomson; Adam P Roberts; Ana M Cerdeño-Tárraga; Hongmei Wang; Matthew T G Holden; Anne Wright; Carol Churcher; Michael A Quail; Stephen Baker; Nathalie Bason; Karen Brooks; Tracey Chillingworth; Ann Cronin; Paul Davis; Linda Dowd; Audrey Fraser; Theresa Feltwell; Zahra Hance; Simon Holroyd; Kay Jagels; Sharon Moule; Karen Mungall; Claire Price; Ester Rabbinowitsch; Sarah Sharp; Mark Simmonds; Kim Stevens; Louise Unwin; Sally Whithead; Bruno Dupuy; Gordon Dougan; Bart Barrell; Julian Parkhill
Journal:  Nat Genet       Date:  2006-06-25       Impact factor: 38.330

3.  Development and optimization of the FAST-ELISA for detecting antibodies to Schistosoma mansoni.

Authors:  K Hancock; V C Tsang
Journal:  J Immunol Methods       Date:  1986-09-27       Impact factor: 2.303

4.  Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice.

Authors:  Chandrabali Ghose; Anuj Kalsy; Alaullah Sheikh; Julianne Rollenhagen; Manohar John; John Young; Sean M Rollins; Firdausi Qadri; Stephen B Calderwood; Ciaran P Kelly; Edward T Ryan
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

5.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.

Authors:  Chandrabali Ghose; Janneke M Verhagen; Xinhua Chen; Jian Yu; Yaoxing Huang; Olivia Chenesseau; Ciarán P Kelly; David D Ho
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

Review 7.  Clostridium difficile spores: a major threat to the hospital environment.

Authors:  Jonathan Barra-Carrasco; Daniel Paredes-Sabja
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

8.  Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.

Authors:  Natalie G Anosova; Anna M Brown; Lu Li; Nana Liu; Leah E Cole; Jinrong Zhang; Hersh Mehta; Harry Kleanthous
Journal:  J Med Microbiol       Date:  2013-03-21       Impact factor: 2.472

9.  Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.

Authors:  Iris Figueroa; Stuart Johnson; Susan P Sambol; Ellie J C Goldstein; Diane M Citron; Dale N Gerding
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more
  11 in total

Review 1.  Sporulation and Germination in Clostridial Pathogens.

Authors:  Aimee Shen; Adrianne N Edwards; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Microbiol Spectr       Date:  2019-11

2.  Identification of Clostridium difficile Immunoreactive Spore Proteins of the Epidemic Strain R20291.

Authors:  Marjorie Pizarro-Guajardo; María Cristina Ravanal; Maria Daniela Paez; Eduardo Callegari; Daniel Paredes-Sabja
Journal:  Proteomics Clin Appl       Date:  2018-04-18       Impact factor: 3.494

3.  Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

Authors:  Caixia Tan; Fei Zhu; Yuanyuan Xiao; Yuqi Wu; Xiujuan Meng; Sidi Liu; Ting Liu; Siyao Chen; Juan Zhou; Chunhui Li; Anhua Wu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

4.  Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile.

Authors:  Jaime Hughes; Carl Aston; Michelle L Kelly; Ruth Griffin
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

5.  Effect of the Synthetic Bile Salt Analog CamSA on the Hamster Model of Clostridium difficile Infection.

Authors:  Amber Howerton; Cale O Seymour; Senthil K Murugapiran; Zhenlin Liao; Jacqueline R Phan; Alan Estrada; Adam J Wagner; Chrisabelle C Mefferd; Brian P Hedlund; Ernesto Abel-Santos
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 6.  Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

Authors:  Séverine Péchiné; Jean F Bruxelle; Claire Janoir; Anne Collignon
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

Review 7.  Learning from Nature: Bacterial Spores as a Target for Current Technologies in Medicine (Review).

Authors:  B G Andryukov; A A Karpenko; I N Lyapun
Journal:  Sovrem Tekhnologii Med       Date:  2020-06-28

Review 8.  Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.

Authors:  Florian Prechter; Katrin Katzer; Michael Bauer; Andreas Stallmach
Journal:  Crit Care       Date:  2017-10-22       Impact factor: 9.097

9.  Emergence of a non-sporulating secondary phenotype in Clostridium (Clostridioides) difficile ribotype 078 isolated from humans and animals.

Authors:  M C Connor; J W McGrath; G McMullan; N Marks; M Guelbenzu; D J Fairley
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

10.  Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with Clostridioides difficile Spores.

Authors:  Ana Raquel Maia; Rodrigo Reyes-Ramírez; Marjorie Pizarro-Guajardo; Anella Saggese; Ezio Ricca; Loredana Baccigalupi; Daniel Paredes-Sabja
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.